ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 337

In Vivo Quantification of Joint Inflammation in a Murine Arthritis Model by Anato-Molecular Imaging

Smriti K. Raychaudhuri1, Anupam Mitra1, Kuang Gong2, Jian Zhou2, Jinyi Qi2, Siba P. Raychaudhuri1 and Abhijit J. Chaudhari3, 1Rheumatology, UC Davis School of Medicine/VA Sacramento Medical Center, Mather, CA, 2Biomedical Engineering, University of California, Davis, Davis, CA, 3Radiology, UC Davis School of Medicine, Sacramento, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: 18FDG PET/CT scan, collagen and inflammatory arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis: Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Positron Emission Tomography (PET) using the radiotracer 18F-fluorodeoxyglucose (FDG) with X-ray Computed Tomography (CT) has the ability of producing an in vivo, three-dimensional quantitative map of joint metabolism (hence inflammation) with co-registered anatomy. We report our experience on using 18F-FDG-microPET/CT as a quantitative marker for monitoring the pathogenesis of inflammatory arthritis in the collagen induced arthritis (CIA) mouse model.

  Methods:

CIA was induced in 8-12 weeks old male DBA/1 mice (n=10) by injecting 100mg bovine collagen type II in 100ml of complete Freund’s adjuvant intradermally into the proximal tail followed by a second intradermal injection of collagen II with incomplete Freund’s adjuvant on day 21. At baseline (1 day before the first injection), 5 randomly chosen animals underwent microPET/CT scan for assessment of baseline status. At days 28 and 56, 5 animals respectively were scanned using microPET/CT, clinical scoring was performed, and joint tissue was derived for histopathological analysis. Quantitative metrics derived from microPET/CT were correlated against clinical score and histopathology outcomes on a per joint and whole limb basis.

  Results:

Images from microPET showed a marked increase in metabolic activity at affected joints of the upper and/or lower extremity at follow-up compared to baseline values. microCT images provided detailed assessment of bone destruction. At the early time point (day 28), increase in metabolic activity by an average of ~20% was observed in the limbs. This further increased to an average of ~50% at day 56 as the disease progressed. Focal activity was visualized at individual affected joints by utilizing advanced resolution-recovery methods. microPET/CT metrics at the early and late time points seemed to broadly correlate with clinical and histopathology scores at the arthritic sites.

  Conclusion:

Our study shows that quantitative metrics associated with disease pathogenesis can be derived from 18F-FDG-microPET/CT. Changes in clinical score and histopathology outcomes seem to correlate with microPET/CT metrics on both a per joint and whole limb basis. microPET/CT may provide a promising tool for understanding the pathogenesis of arthritis and for monitoring response to new treatments in experimental arthritic models.

Description: Description: Description: C:UsersAbhijitDesktopPublications2012ACR_annual_meetingchaudhari_ACR_mouse_rev1_filesimage001.png

Figure 1: An 18F-FDG-microPET scan of the limb of an animal with collagen induced arthritis. Resolution recovery methods allow unparalleled visualization of the details of inflammatory activity.


Disclosure:

S. K. Raychaudhuri,
None;

A. Mitra,
None;

K. Gong,
None;

J. Zhou,
None;

J. Qi,
None;

S. P. Raychaudhuri,
None;

A. J. Chaudhari,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/in-vivo-quantification-of-joint-inflammation-in-a-murine-arthritis-model-by-anato-molecular-imaging/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology